UB-851

· UBI Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UB-851, covering 2023-12-06 to 2023-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare the Safety and Efficacy of UB-851 and Eprex® [Phase 3]